http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107050065-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-742 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-744 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-744 |
| filingDate | 2017-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107050065-B |
| titleOfInvention | New application of bifidobacterium tetragenous live bacteria composition |
| abstract | The invention discloses a new application of a bifidobacterium tetragenous viable bacteria composition, belonging to the technical field of medicines. The invention discloses an application of a bifidus tetragenous viable bacteria composition in preparing an auxiliary hypoglycemic medicament or health food or food, an application of the bifidus tetragenous viable bacteria composition in preparing an auxiliary glycated albumin-reducing medicament or health food or food, and an application of the bifidus tetragenous viable bacteria composition in preparing an auxiliary hypoglycemic medicament or health food or food suitable for patients with type II diabetes and patients with combined insulin. The invention discovers a new application of the bifidobacterium tetragenous viable bacteria composition, expands the application range of the bifidobacterium tetragenous viable bacteria composition, expands the clinical application range of the bifidobacterium tetragenous viable bacteria composition from a digestive department to a new diabetes endocrine department, belongs to a probiotic micro-ecological preparation, has harmless components and has no side effect on human bodies. |
| priorityDate | 2017-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 192.